589 related articles for article (PubMed ID: 34708251)
1. Genomics of Alzheimer's disease implicates the innate and adaptive immune systems.
Li Y; Laws SM; Miles LA; Wiley JS; Huang X; Masters CL; Gu BJ
Cell Mol Life Sci; 2021 Dec; 78(23):7397-7426. PubMed ID: 34708251
[TBL] [Abstract][Full Text] [Related]
2. Functional insight into LOAD-associated microglial response genes.
Jonas LA; Jain T; Li YM
Open Biol; 2022 Jan; 12(1):210280. PubMed ID: 35078351
[TBL] [Abstract][Full Text] [Related]
3. Genetics of Alzheimer's disease.
Chouraki V; Seshadri S
Adv Genet; 2014; 87():245-94. PubMed ID: 25311924
[TBL] [Abstract][Full Text] [Related]
4. The role of innate immune genes in Alzheimer's disease.
Griciuc A; Tanzi RE
Curr Opin Neurol; 2021 Apr; 34(2):228-236. PubMed ID: 33560670
[TBL] [Abstract][Full Text] [Related]
5. Genomics of Alzheimer Disease: A Review.
Rosenberg RN; Lambracht-Washington D; Yu G; Xia W
JAMA Neurol; 2016 Jul; 73(7):867-74. PubMed ID: 27135718
[TBL] [Abstract][Full Text] [Related]
6. The neuronal-specific isoform of BIN1 regulates β-secretase cleavage of APP and Aβ generation in a RIN3-dependent manner.
Bhattacharyya R; Teves CAF; Long A; Hofert M; Tanzi RE
Sci Rep; 2022 Mar; 12(1):3486. PubMed ID: 35241726
[TBL] [Abstract][Full Text] [Related]
7. The complex genetic architecture of Alzheimer's disease: novel insights and future directions.
Andrews SJ; Renton AE; Fulton-Howard B; Podlesny-Drabiniok A; Marcora E; Goate AM
EBioMedicine; 2023 Apr; 90():104511. PubMed ID: 36907103
[TBL] [Abstract][Full Text] [Related]
8. Expression of novel Alzheimer's disease risk genes in control and Alzheimer's disease brains.
Karch CM; Jeng AT; Nowotny P; Cady J; Cruchaga C; Goate AM
PLoS One; 2012; 7(11):e50976. PubMed ID: 23226438
[TBL] [Abstract][Full Text] [Related]
9. Microglial genes regulating neuroinflammation in the progression of Alzheimer's disease.
Villegas-Llerena C; Phillips A; Garcia-Reitboeck P; Hardy J; Pocock JM
Curr Opin Neurobiol; 2016 Feb; 36():74-81. PubMed ID: 26517285
[TBL] [Abstract][Full Text] [Related]
10. Emerging roles of innate and adaptive immunity in Alzheimer's disease.
Chen X; Holtzman DM
Immunity; 2022 Dec; 55(12):2236-2254. PubMed ID: 36351425
[TBL] [Abstract][Full Text] [Related]
11. TREM2, Microglia, and Neurodegenerative Diseases.
Yeh FL; Hansen DV; Sheng M
Trends Mol Med; 2017 Jun; 23(6):512-533. PubMed ID: 28442216
[TBL] [Abstract][Full Text] [Related]
12. Role of the immune system in the pathogenesis, prevention and treatment of Alzheimer's disease.
Blasko I; Grubeck-Loebenstein B
Drugs Aging; 2003; 20(2):101-13. PubMed ID: 12534311
[TBL] [Abstract][Full Text] [Related]
13. Reduction of the expression of the late-onset Alzheimer's disease (AD) risk-factor
Andrew RJ; De Rossi P; Nguyen P; Kowalski HR; Recupero AJ; Guerbette T; Krause SV; Rice RC; Laury-Kleintop L; Wagner SL; Thinakaran G
J Biol Chem; 2019 Mar; 294(12):4477-4487. PubMed ID: 30692199
[TBL] [Abstract][Full Text] [Related]
14. Curcumin restores innate immune Alzheimer's disease risk gene expression to ameliorate Alzheimer pathogenesis.
Teter B; Morihara T; Lim GP; Chu T; Jones MR; Zuo X; Paul RM; Frautschy SA; Cole GM
Neurobiol Dis; 2019 Jul; 127():432-448. PubMed ID: 30951849
[TBL] [Abstract][Full Text] [Related]
15. Aducanumab, gantenerumab, BAN2401, and ALZ-801-the first wave of amyloid-targeting drugs for Alzheimer's disease with potential for near term approval.
Tolar M; Abushakra S; Hey JA; Porsteinsson A; Sabbagh M
Alzheimers Res Ther; 2020 Aug; 12(1):95. PubMed ID: 32787971
[TBL] [Abstract][Full Text] [Related]
16. Chronic Toxoplasma gondii infection enhances β-amyloid phagocytosis and clearance by recruited monocytes.
Möhle L; Israel N; Paarmann K; Krohn M; Pietkiewicz S; Müller A; Lavrik IN; Buguliskis JS; Schott BH; Schlüter D; Gundelfinger ED; Montag D; Seifert U; Pahnke J; Dunay IR
Acta Neuropathol Commun; 2016 Mar; 4():25. PubMed ID: 26984535
[TBL] [Abstract][Full Text] [Related]
17. Effects of Alzheimer's Disease-Associated Risk Loci on Amyloid-β Accumulation in the Brain of Idiopathic Normal Pressure Hydrocephalus Patients.
Laiterä T; Paananen J; Helisalmi S; Sarajärvi T; Huovinen J; Laitinen M; Rauramaa T; Alafuzoff I; Remes AM; Soininen H; Haapasalo A; Jääskeläinen JE; Leinonen V; Hiltunen M
J Alzheimers Dis; 2017; 55(3):995-1003. PubMed ID: 27802227
[TBL] [Abstract][Full Text] [Related]
18. Alzheimer's disease risk genes and mechanisms of disease pathogenesis.
Karch CM; Goate AM
Biol Psychiatry; 2015 Jan; 77(1):43-51. PubMed ID: 24951455
[TBL] [Abstract][Full Text] [Related]
19. Development of amyloid beta-directed antibodies against Alzheimer's disease: Twists and turns.
Lu D; Dou F; Gao J
Drug Discov Ther; 2023; 17(6):440-444. PubMed ID: 38220210
[TBL] [Abstract][Full Text] [Related]
20. Systemic vaccination with anti-oligomeric monoclonal antibodies improves cognitive function by reducing Aβ deposition and tau pathology in 3xTg-AD mice.
Rasool S; Martinez-Coria H; Wu JW; LaFerla F; Glabe CG
J Neurochem; 2013 Aug; 126(4):473-82. PubMed ID: 23672786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
